ATE458749T1 - Neuartige mit taxan verwandte peptide und deren verwendung - Google Patents

Neuartige mit taxan verwandte peptide und deren verwendung

Info

Publication number
ATE458749T1
ATE458749T1 AT06026026T AT06026026T ATE458749T1 AT E458749 T1 ATE458749 T1 AT E458749T1 AT 06026026 T AT06026026 T AT 06026026T AT 06026026 T AT06026026 T AT 06026026T AT E458749 T1 ATE458749 T1 AT E458749T1
Authority
AT
Austria
Prior art keywords
related peptides
taxan
novel
novel taxan
peptides
Prior art date
Application number
AT06026026T
Other languages
English (en)
Inventor
Giovanni Scambia
Cristiano Ferlini
Giuseppe Campiani
Caterina Fattorusso
Original Assignee
Giuseppe Campiani
Caterina Fattorusso
Univ Cattolica Sacro Cuore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuseppe Campiani, Caterina Fattorusso, Univ Cattolica Sacro Cuore filed Critical Giuseppe Campiani
Application granted granted Critical
Publication of ATE458749T1 publication Critical patent/ATE458749T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06026026T 2006-12-15 2006-12-15 Neuartige mit taxan verwandte peptide und deren verwendung ATE458749T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06026026A EP1932852B1 (de) 2006-12-15 2006-12-15 Neuartige mit Taxan verwandte Peptide und deren Verwendung

Publications (1)

Publication Number Publication Date
ATE458749T1 true ATE458749T1 (de) 2010-03-15

Family

ID=37964135

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06026026T ATE458749T1 (de) 2006-12-15 2006-12-15 Neuartige mit taxan verwandte peptide und deren verwendung

Country Status (3)

Country Link
EP (1) EP1932852B1 (de)
AT (1) ATE458749T1 (de)
DE (1) DE602006012515D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11021514B2 (en) 2016-06-01 2021-06-01 Athira Pharma, Inc. Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
JP2004520803A (ja) * 2000-04-21 2004-07-15 コリクサ コーポレイション 尋常性挫瘡の治療および診断のための組成物および方法
CA2480419A1 (en) * 2002-03-28 2003-10-09 Yamanouchi Pharmaceutical Co., Ltd. Antiopoietin-related growth factor

Also Published As

Publication number Publication date
DE602006012515D1 (de) 2010-04-08
EP1932852B1 (de) 2010-02-24
EP1932852A1 (de) 2008-06-18
EP1932852A8 (de) 2008-10-29

Similar Documents

Publication Publication Date Title
ZA201001054B (en) Peptide with reduced dimer formation
CY1113188T1 (el) Τροποποιημενα fgf-21 πολυπεπτιδια και οι χρησεις τους
CY1113199T1 (el) Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης
CY1120206T1 (el) Μεθοδοι για τη συγκλινουσα συνθεση παραγωγων καλιχεαμικινης
ATE523544T1 (de) Alkylierte aminopropylierte ethyendiamine und verwendungen davon
MY161534A (en) Methods of purifying polypeptides
DE602007012559D1 (de) H die schleimhaut
EA201001356A1 (ru) Новые замещенные имидазохинолины
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
CL2007003774A1 (es) Compuestos derivados de quinazolina sustituidos, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, aterosclerosis y artritis.
ECSP11010760A (es) Derivados de quinoxalindiona
HN2011001697A (es) Compuesto amino pirazol
EP2195331A4 (de) Synthetische, apolipoprotein e nachahmende polypeptide und anwendungsverfahren
ATE486079T1 (de) Azatricyclische verbindungen und deren verwendung
ATE514765T1 (de) Azeotropartige zusammensetzungen mit 1,1,1,2,3,3- hexafluor-3-methoxypropan und 1-brompropan
CR20110202A (es) Antagonistas de la via hedgehog de ftalazina disustituida
CR11126A (es) Inhibicion de metastasis de tumor por anticuerpos anti neuropilina 2
NO20081102L (no) Anvendelse av modifiserte trematerialer for fremstilling av gjenstander
ATE523543T1 (de) Alkylierte aminoproyliertes methylen-di- (cyclohexylamin) und verwendungen davon
DE502006004472D1 (de) Organische elektrolumineszenzvorrichtungen
CL2008003602A1 (es) Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.
ATE458749T1 (de) Neuartige mit taxan verwandte peptide und deren verwendung
EA200971103A1 (ru) Иммуноцитокины для лечения рака в сочетании с химиотерапевтическими агентами
DE602007002716D1 (de) Neuroprotektive verbindungen und deren verwendungen
CL2008000865A1 (es) Compuestos derivados de benzimidazol-2-ona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de un trastorno psicotico o un deterioro cognitivo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties